Basic Information
Basic information for AL162231.2-201-62aa
Peptide Name AL162231.2-201-62aa
Genome Position chr9:34678159-34678268,34680906-34680981[+]
Species Human
Peptide Sequence MFPALECWTPSSSVLELGLSLLAPQPADGLLWDLVIVLLWWYYYYSARFWFYFSSWELPSRR
Peptide Length 62
Unique No (AL162231.2-202-62aa)
Grand Average of Hydropathicity 0.3742
Relative Molecular Mass 8537.43
Experimental Evidences 3:lncORF,m6A,ribo
lncRNA ID/Name ENSG00000230074;AL162231.2
Transcript ID/Name ENST00000434627;AL162231.2-201
Transcript Length 665
Coding Ability 0.415
DNA Sequence Corresponding to Peptide ATGTTTCCTGCCCTTGAATGTTGGACTCCAAGTTCTTCAGTTTTGGAACTCGGACTGTCTCTCCTTGCTCCTCAGCCTGCAGACGGCCTATTGTGGGACCTTGTGATCGTGTTGTTGTGGTGGTATTACTACTACTCAGCAAGATTCTGGTTTTACTTCTCATCTTGGGAGTTACCATCAAGACGT
Experimental Evidences
   lncORF
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :